AI Summary
✦ ClarthaGodrej Agrovet is an agri-business company supplying products that improve crop and livestock yields. Animal Feed, Vegetable Oil, Crop Protection, Dairy, Poultry and Processed Food drive revenue, with oil palm plantations supporting crude palm oil and palm-kernel products. Revenue grew 9.1% year-on-year, while the recent earnings miss suggests limited near-term operating leverage and keeps growth dependent on segment execution. Profit increased 10.0%, and stable margins indicate earnings broadly tracked revenue without clear expansion. ROE is unavailable, while debt/equity of 72.75 implies substantial leverage that can amplify reported returns but increases financial risk. At 23.4 times earnings, valuation appears fair relative to current growth, rather than discounted. The key open question is whether feed, crop protection and oil-palm operations can improve growth without margin pressure.
Price Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 5 analysts
Fundamentals
Fundamentals institutional score is 64 using growth durability 63.7.
Valuation
Valuation institutional score is 72 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 84 using mean target upside 34.7%; dispersion penalty 11.7; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 58 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 3 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. valuation and analyst consensus provide support, while market sentiment remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 7.0% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -0.71). Confidence: 82%.
Live forward EPS implies next-12-month EPS of ₹33.55. Applying the stock's normalized valuation corridor produces a fair range of ₹765.95 to ₹1,048.77, with base value near ₹843.11 (+51.6% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹33.55
Forward P/E
16.6x
Base Fair Value
₹843.11
Fair Range
₹765.95 - ₹1,048.77
Upside To Base
+51.6%
Estimate Source
Live forward EPS
Growth Estimate
-16.3%
5Y Average
24.03
Current
23.37
Overvalued
31.26
Undervalued
22.83
5Y Average
14.62
Current
14.56
Overvalued
17.21
Undervalued
12.22
5Y Average
1.02
Current
1.02
Overvalued
1.18
Undervalued
0.87
Peers & Comparison
Sector: Consumer Staples · Theme: Agro Products
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
ATUL LTD ATULDiversified Chemicals | +25.0% | 12.0% | 25.4x Undervalued | -81% vs avg | +2.4% |
AARTI INDUSTRIES LTD AARTIINDSpecialty Chemicals | +42.5% | 5.9% | 34.3x Undervalued | -74% vs avg | +33.9% |
BATA INDIA LTD BATAINDIAFootwear | +5.0% | 3.8% | 68.2x Undervalued | -48% vs avg | -39.1% |
EXIDE INDUSTRIES LTD EXIDEINDBatteries | +17.7% | 4.9% | 44.2x Undervalued | -66% vs avg | +29.7% |
MAX FINANCIAL SERV LTD MFSLInsurance | -40.2% | 0.2% | 631.0x Premium | +382% vs avg | -3.8% |
GLAXOSMITHKLINE PHARMA LT GLAXOPharmaceuticals | +16.6% | 27.0% | 41.2x Undervalued | -69% vs avg | -3.3% |
ASTRAL LIMITED ASTRALBuilding Products - Pipes | +24.2% | 8.2% | 72.1x Undervalued | -45% vs avg | +4.5% |
GODREJ AGROVET LIMITED trades at a discount (23.9x vs peer avg 130.9x), suggesting potential undervaluation relative to the Agro Products cohort. Peers include ATUL LTD, AARTI INDUSTRIES LTD, BATA INDIA LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹2.21K CrJun 2026Latest net profit
₹184 CrJun 2026Latest EPS
₹9.54Jun 2026Net margin
10.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 1,820 | 1,951 | 1,820 | 1,497 | 1,741 | 1,848 | 1,869 | 1,550 | 2,007 | 2,000 | 2,070 | 1,668 | 2,205 |
| Expenses + | 1,669 | 1,776 | 1,659 | 1,407 | 1,527 | 1,627 | 1,674 | 1,420 | 1,748 | 1,804 | 1,858 | 1,562 | 1,978 |
| Operating Profit | 151 | 174 | 161 | 90 | 214 | 222 | 195 | 130 | 259 | 196 | 212 | 105 | 228 |
| OPM % | 8% | 9% | 9% | 6% | 12% | 12% | 10% | 8% | 13% | 10% | 10% | 6% | 10% |
| Other Income + | 12 | 46 | 11 | 7 | 18 | 12 | 76 | 3 | 12 | 90 | -7 | 24 | 64 |
| Interest | 18 | 17 | 14 | 13 | 19 | 27 | 22 | 16 | 20 | 27 | 23 | 16 | 18 |
| Depreciation | 30 | 29 | 29 | 32 | 30 | 31 | 31 | 31 | 32 | 32 | 32 | 32 | 31 |
| Profit before tax | 115 | 174 | 129 | 51 | 183 | 175 | 218 | 87 | 219 | 226 | 150 | 81 | 242 |
| Tax % | 25% | 22% | 24% | 29% | 25% | 24% | 24% | 22% | 23% | 22% | 23% | 21% | 24% |
| Net Profit + | 86 | 136 | 98 | 36 | 136 | 132 | 166 | 68 | 169 | 177 | 116 | 65 | 184 |
| EPS in Rs | 4.48 | 7.09 | 5.12 | 1.90 | 7.09 | 6.86 | 8.64 | 3.54 | 8.78 | 9.21 | 6.01 | 3.37 | 9.54 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome